SCHEMBL4513229

SCHEMBL4513229

Cc1ccc2oc(-c3cccc(NC(=O)c4ccc(Cl)nc4)c3)nc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.65
HPGD P15428 3/20 0.65
HSD17B10 Q99714 3/20 0.65
GAA P10253 1/20 0.65
DUSP1 P28562 6/20 0.65
MAPT P10636 6/20 0.63
LMNA P02545 1/20 0.61
P2RY14 Q15391 1/20 0.60
POLB P06746 2/20 0.59
MAPK1 P28482 2/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
KDM4E B2RXH2 3/20 0.59
NPC1 O15118 2/20 0.59
ALDH1A1 P00352 2/20 0.59
RAB9A P51151 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
HTT P42858 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
USP2 O75604 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4501249 0.86 HPGD (0.72) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4518500 0.84 MAPT (0.75) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4514921 0.84 DUSP1 (0.72) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4523637 0.82 HPGD (0.66) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4503739 0.81 TP53 (0.84) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4518972 0.81 MAPT (0.73) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4517932 0.81 HPGD (0.82) TP53HPGDHSD17B10GAADUSP1
SCHEMBL4501791 0.81 TP53 (0.73) TP53HPGDHSD17B10GAADUSP1
SCHEMBL26687955 0.80 TP53 (0.82) TP53HPGDHSD17B10GAADUSP1
SCHEMBL17544303 0.79 MAPT (0.67) TP53HPGDHSD17B10GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258917-A1 Benzoxazoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258917-A1 Benzoxazoles Useful in the Treatment of Inflammation IL4I1, EPX, IL4 TP53 2523/4885HPGD 411/4885HSD17B10 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.